MillerKM, FosterNC, BeckRW, BergenstalRM, DuBoseSN, DiMeglioLA, MaahsDM, TamborlaneWV; T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic Registry. Diabetes Care, 2015; 38: 971–78.
2.
DovcK, TelicSS, LusaL, BratanicN, Zerjav-TansekM, KotnikP, StefanijaMA, BattelinoT, BratinaN. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis. Diabetes Technol Ther, 2014; 16: 33–40.
3.
RosenbauerJ, DostA, KargesB, HungeleA, StahlA, BächleC, GerstlEM, KastendieckC, HoferSE, HollRW; DPV Initiative and the German BMBF Competence Network Diabetes Mellitus. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care, 2012; 35: 80–86.
4.
RewersMJ, PillayK, de BeaufortC, CraigME, HanasR, AceriniCL, MaahsDM; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes, 2014; 15Suppl 20: 102–14.
5.
ChiangJL, KirkmanMS, LaffelLM, PetersAL; Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care, 2014; 37: 2034–54.
6.
O'ConnellSM, CooperMN, BulsaraMK, DavisEA, JonesTW. Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000–2009. Diabetes Care, 2011; 34: 2379–80.
7.
KargesB, RosenbauerJ, KapellenT, WagnerVM, SchoberE, KargesW, HollRW. Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012. PLoS Med, 2014; 11: e1001742.
8.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993; 329: 977–86.
9.
WoodJR, MillerKM, MaahsDM, BeckRW, DiMeglioLA, LibmanIM, QuinnM, TamborlaneWV, WoernerSE; T1D Exchange Clinic Network. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care, 2013; 36: 2035–37.
10.
ClarkeWL, CoxD, Gonder-FrederickLA, et al.Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care, 1987; 10: 622–28.
11.
ParkesJL, SlatinSL, PardoS, et al.A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care, 2000; 23: 1143–48.
12.
BrazgRL, KlaffLJ, ParkinCG. Performance variability of seven commonly used self-monitoring of blood glucose systems: clinical considerations for patients and providers. J Diabetes Sci Technol, 2013; 7: 144–52.
13.
FreckmannG, SchmidC, BaumstarkA, et al.System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol, 2012; 6: 1060–75.
14.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359: 1464–76.
15.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care, 2009; 32: 1947–53.
16.
VehikK, CuthbertsonD, BoulwareD, BeamCA, RodriguezH, LegaultL, HyytinenM, RewersMJ, SchatzDA, KrischerJP; TEDDY, TRIGR, Diabetes Prevention Trial–Type 1, and Type 1 Diabetes TrialNet Natural History Study Groups. Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth. Diabetes Care, 2012; 35: 1821–25.
17.
PhillipM, BattelinoT, AtlasE, et al.Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med, 2013; 368: 824–33.
18.
WeinzimerSA, SteilGM, SwanKL, et al.Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care, 2008; 31: 934–39.
19.
ElleriD, AllenJM, KumareswaranK, et al.Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care, 2013; 36: 838–44.
20.
HovorkaR, AllenJM, ElleriD, et al.Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet, 2010; 375: 743–51.
21.
KowalskiA. Pathway to artificial pancreas systems revisited: moving downstream. Diabetes Care, 2015; 38: 1036–43.
22.
KnipM, VirtanenSM, AkerblomHK. Infant feeding and the risk of type 1 diabetes. Am J Clin Nutr, 2010; 91: 1506S–13S.
23.
SkylerJS, KrischerJP, WolfsdorfJ, et al.Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1. Diabetes Care, 2005; 28: 1068–76.
24.
VehikK, CuthbertsonD, RuhligH, et al.Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial. Diabetes Care, 2011; 34: 1585–90.
